EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC
Clinical trial NCT05075577 · TERMINATED
Trial details
- NCT number
- NCT05075577
- Sponsor
- ESSA Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2024-10-31
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.